Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I
With a successful phase I clinical trial, Danish biotech Bavarian Nordic has come a step…
09/06/2020 - 3 minutes
Bavarian Nordic
Update: First Ever Ebola Vaccine Gets US and EU Approval
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
20/12/2019 - 2 minutes
Yet Another Checkpoint Inhibitor Goes to Trial with Bavarian Nordic’s Cancer Vaccine
Bavarian Nordic and AstraZeneca collaborate on a treatment that uses a cancer vaccine along with…
28/02/2018 - 3 minutes
Trouble in Paradise: How Biotech is Fighting Tropical Diseases
Tropical diseases are often neglected until an outbreak causes worldwide panic. Here’s how European biotech…
25/07/2017 - 6 minutes
Danish Biotech Reports Positive Phase II data for a Common Cold Vaccine
Bavarian Nordic has announced positive Phase II results for its universal vaccine against the common…
28/06/2017 - 2 minutes
Bavarian Nordic gets hold of Opdivo for new Combination Phase II trial
Just after a major clinical failure, BMS is now shipping Opdivo to Bavarian Nordic for…
17/08/2016 - 3 minutes
Danish ‘safer’ vaccine for Smallpox gets US order worth €90M
Bavarian Nordic will receive €90M from the US' BARDA for its nonreplicating smallpox vaccine - which…
24/05/2016 - 2 minutes
Here are 12 Biotechs you need to know in Copenhagen – Skål!
With its canals, the Little Mermaid and the oldest amusement park in the world, Copenhagen…
03/05/2016 - 6 minutes
Did Bavarian Nordic cheat on its clinical results?
The hedge fund Kerrisdale Capital just published a report explaining its position in Bavarian Nordic,…
05/08/2015 - 3 minutes
A 100% Successful Ebola Vaccine Available in a Record Time
It's a really good news in the fight against Ebola. A vaccine has shown 100% success…
04/08/2015 - 3 minutes
European Union supports Bavarian Nordic to cure Ebola
Bavarian Nordic has been granted €50M loan from the European Investment Bank (EIB) to support…
15/05/2015 - 2 minutes
Bristol-Myers Squibb signs an agreement for Bavarian Nordic’s PROSTVAC
Bristol-Myers Squibb signs an exclusive agreement with Bavarian Nordic for PROSTVAC, a prostate-specific antigen-targeting cancer…
04/03/2015 - 2 minutes
